Section: Press - posted in 2013

15 results found. Viewing page 1 of 2. Go to page 1 2   Next
  • New Case Study Research Available at No Cost to Dermatologist Physicians and Healthcare Providers

    Director of Dermatopathology at Inform Diagnostics, Dr. Elsa Velazquez-McGuirk, launches effort to educate and inform dermatologists by examining the principles of providing accurate and definitive diagnoses for complex cases. Today, Inform Diagnostics, the nation’s largest independent anatomical pathology provider, released five teaching case studies examining the principles of providing ...
    Continue Reading
  • Miraca Life Sciences Now Offers Genetic Testing Protocol for Chronic Myelogenous Leukemia (CML)

    Sophisticated analytical sensitivity of Inform Diagnostics RT-PCR test process benefits hematology-oncologists to confirm CML diagnosis, identify treatment resistant BCR-ABL fusion transcripts in patients and monitor disease. Physicians treating patients with chronic myelogenous leukemia (CML) can now optimize their patient outcomes with the Inform Diagnostics BCR-ABL1 major quantitative testing ...
    Continue Reading
  • Miraca Life Sciences Offers Webinars on PTEN and ERG Testing

    Learn how to leverage PTEN and ERG testing as a prognostic marker for more aggressive cancers In November, Inform Diagnostics (MLS) will offer a series of webinars demonstrating the value of molecular markers, such as PTEN and ERG, in diagnosing prostate cancer. PTEN loss correlates with more advanced stage of prostate cancer, making it a prognostic marker for more aggressive cancers. PTEN is a ...
    Continue Reading
  • Miraca Life Sciences Announces Significant Plans at the Annual Meeting for ASH

    Inform Diagnostics (MLS), the leading pathology services provider that collaborates to make patients and practices better, announced today that it will have a significant presence at the Annual Meeting for the American Society of Hematology (ASH), a conference offering roundtable discussions, hands-on training and health policy updates, on December 7-10 in New Orleans, Louisiana. Visitors to ...
    Continue Reading
  • Miraca Life Sciences Announces That It Has Acquired PLUS Diagnostics

    Inform Diagnostics’ Acquisition of PLUS Diagnostics Will Create the Largest Independent Anatomic Pathology Laboratory Company in the United States Inform Diagnostics (“MLS”), the leading provider of expert anatomic pathology services, today announced that it has acquired PLUS Diagnostics (“PLUS”) from Water Street Healthcare Partners, a strategic investor focused ...
    Continue Reading
  • Miraca Life Sciences Implements DNA Mismatch Repair Gene Mutation Screening Program

    Inform Diagnostics (MLS), the leading pathology services provider that collaborates to make patients and practices better, is pleased to announce the results of a screening program implemented in 2010 which tests pre-cancerous polyps for DNA mismatch repair (MMR) abnormalities. Throughout this program, MLS leveraged its unique expertise and systematic approach to pathologic evaluations to ensure ...
    Continue Reading
  • Miraca Life Sciences Announces Significant Plans at the Annual Meeting for LUGPA

    Inform Diagnostics (MLS), the leading pathology services provider that collaborates to make patients and practices better, announced today that it will have a significant presence at the Annual Meeting for the Large Urology Group Practice Association (LUGPA), a conference offering roundtable discussions, hands-on training and health policy updates, on November 7-9 in Chicago, Illinois. Visitors to ...
    Continue Reading
  • Miraca Life Sciences Names Elsa Velazquez-McGuirk, MD, as Director of Dermatopathology

    Elsa Velazquez-McGuirk, MD, will succeed Evan Farmer, MD, beginning November 1, 2013 Inform Diagnostics, the leading pathology services provider that collaborates to make patients and practices better, is pleased to announce that Elsa Velazquez-McGuirk, M.D. has accepted the position of Director of Dermatopathology for Inform Diagnostics, effective November 1. In her new role, Dr. ...
    Continue Reading
  • Analysis of Genetic Abnormality Affecting PTEN and ERG Genes May Provide Important Risk-assessment for Prostate Cancer Patients

    On July 14, 2013, Inform Diagnostics announced a new genomic testing protocol that will help Urologists guide better treatment decisions and determine outcomes in prostate cancer patients. Inform Diagnostics says two important genetic abnormalities: one characterized by loss of a protective gene known as PTEN and another by overexpression of the cancer-promoting gene ERG occur in 50-60 percent of ...
    Continue Reading
  • Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integration

    Enhanced Communication between Dermatologists and Pathologists Modernizing Medicine ®, the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, specialty-specific electronic medical record (EMR) system, and Inform Diagnostics (MLS), a specialist in the development and commercialization of subspecialty expert anatomic pathology services, announced today that they are ...
    Continue Reading
15 results found. Viewing page 1 of 2. Go to page 1 2   Next